Publication | Closed Access

OGA activated glycopeptide-based nano-activator to activate PKM2 tetramerization for switching catabolic pathways and sensitizing chemotherapy resistance

NanomedicineChemotherapy ResistancePkm2 TetramerizationEngineeringPolymer-drug ConjugateMedicineDrug DiscoveryCatabolic PathwaysTumor TargetingAnti-cancer AgentPharmacologyBiomolecular Engineering